References
- Yang ZS, Mu J. Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: a continued promise for neuroprotection. Med Gas Res. 2017;7(1):68–73.
- Sukockienė E, Laučkaitė K, Jankauskas A, et al. Crucial role of carotid ultrasound for the rapid diagnosis of hyperacute aortic dissection complicated by cerebral infarction: a case report and literature review. Medicina (Kaunas). 2016;52(6):378–388.
- Folgoas E, Toulgoat F, Sévin M, et al. [Ischemic stroke related to pauci-symptomatic acute aortic dissection. Risks of intravenous thrombolysis]. Rev Neurol (Paris)). 2012;168(4):357–362.
- Jo KW, Park IS, Kim YD, et al. Unexpected complication of intravenous recombinant tissue plasminogen activator thrombolysis in a patient with acute ischemic stroke: aortic dissection. Korean J Cerebrovasc Surg. 2009;11:204–206.
- Xu X, Li C, Wan T, et al. Risk factors for hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction: a retrospective single-center study. World Neurosurg. 2017;101:155–160.
- Tsivgoulis G, Vadikolias K, Heliopoulos I, et al. Aortic arch dissection causing acute cerebral ischemia: an uncommon contraindication for intravenous thrombolysis. Circulation. 2011;124(5):657–658.
- Hagan PG, Nienaber CA, Isselbacher EM, et al. The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.
- Choi N, Yoon J-E, Park B-W, et al. Delayed surgery for aortic dissection after intravenous thrombolysis in acute ischemic stroke. Korean J Thorac Cardiovasc Surg. 2016;49(5):392–396.
- Rodrıíguez-Luna D, Vilar RM, Peinazo M, et al. Intravenous thrombolysis in an elderly patient with acute ischemic stroke masking aortic dissection. J Stroke Cerebrovasc Dis. 2011;20(6):559–561.
- Ohara T, Koga M, Tokuda N, et al. Rapid identification of type a aortic dissection as a cause of acute ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25(8):1901–1906.
- Lantos J, Nagy A, Hegedűs Z, et al. [Thrombolysis in case of ischemic stroke caused by aortic dissection]. Ideggyogy Sz. 2017;70(1-2):69–72.
- Do YR. Aortic dissection after intravenous thrombolysis in acute cerebral infarction. Kosin Med J. 2017;32(1):127–132.
- Kazmi SO, Achi O, Damani R. Full-dose thrombolysis for a right middle cerebral artery stroke after an acute aortic dissection. Ann Indian Acad Neurol. 2018;21(3):223–224.
- Hong KS, Park SY, Whang S, et al. Intravenous recombinant tissue plasminogen activator thrombolysis in a patient with acute ischemic stroke secondary to aortic dissection. J Clin Neurol. 2009;5(1):49–52.
- Matrat A, De Mazancourt P, Derex L, et al. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke. Thromb Res. 2013;131(1):e45–e48.
- Skeik N, Gits CC, Ehrenwald E, et al. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Vasc Endovascular Surg. 2013;47(7):519–523.
- Vandelli L, Marietta M, Gambini M, et al. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2015;24(2):394–400.
- Zhang YL, Cui Y, Cai L, et al. The influence of ateplase on blood coagulation function in patients treated with intravenous thrombolysis within 24 hours. Shanxi Med J. 2015;44:1591–1594.